Current Neuro-Oncology

Volume 22 Number 18
30 September 2020

Home > Publications > Current Neuro-Oncology > Volume 22, Year 2020 > Number 18, 30 September

Bastola S, Pavlyukov MS, Yamashita D, Ghosh S, Cho H, Kagaya N, Zhang Z, Minata M, Lee Y, Sadahiro H, Yamaguchi S, Komarova S, Yang E, Markert J, Nabors LB, Bhat K, Lee J, Chen Q, Crossman DK, Shin-Ya K, Nam DH, Nakano I.
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Nat Commun. 2020 Sep 16, 2020;11(1):4660
. doi: 10.1038/s41467-020-18189-y. PMID: 32938908. Laboratory investigation. ˍ

Csutak C, Ștefan PA, Lenghel LM, Moroșanu CO, Lupean RA, Șimonca L, Mihu CM, Lebovici A.
Differentiating High-Grade Gliomas from Brain Metastases at Magnetic Resonance: The Role of Texture Analysis of the Peritumoral Zone.
Brain Sci. 2020 Sep 16, 2020;10(9):E638
. doi: 10.3390/brainsci10090638. PMID: 32947822. Observational study. ˍ

Chen H, Kuhn J, Lamborn KR, Abrey LE, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WKA, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, Prados MD, Cloughesy TF, Wen PY, Gilbert MR.
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.
Neurooncol Adv. 2020 Sep 17, 2020;2(1):vdaa124
. doi: 10.1093/noajnl/vdaa124. PMID: 33235994. Interventional study. ˍ

Nguyen TB, Melkus G, Taccone M, Moldovan ID, Ghinda D, Gotfrit R, Torres CH, Zakhari N, Chakraborty S, Woulfe J, Jansen G, McInnes MD, Thornhill RE, Cameron I, AlKherayf F.
Preoperative Determination of Isocitrate Dehydrogenase Mutation in Gliomas Using Spectral Editing MRS: A Prospective Study.
J Magn Reson Imaging. 2020 Sep 17, 2021;53(2):416-426
. doi: 10.1002/jmri.27366. PMID: 32940938. Observational study. ˍ

Hanson D, Hoffman LM, Nagabushan S, Goumnerova LC, Rathmann A, Vogel T, Ziegler DS, Chi S.
A modified IRS-III chemotherapy regimen leads to prolonged survival in children with embryonal tumor with multilayer rosettes.
Neurooncol Adv. 2020 Sep 18, 2020;2(1):vdaa120
. doi: 10.1093/noajnl/vdaa120. PMID: 33196040. Case report. ˍ

Zhang GB, Huang HW, Li HY, Zhang XK, Wang YG, Lin S.
Intracranial chordoid glioma: A clinical, radiological and pathological study of 14 cases.
J Clin Neurosci. 2020 Sep 18, 2020;80:267-273
. doi: 10.1016/j.jocn.2020.09.019. PMID: 33099359. Case report. ˍ

Wang Y, Liang D, Chen J, Chen H, Fan R, Gao Y, Gao Y, Tao R, Zhang H.
Targeted Therapy with Anlotinib for a Patient with an Oncogenic FGFR3-TACC3 Fusion and Recurrent Glioblastoma.
Oncologist. 2020 Sep 19, 2021;26(3):173-177
. doi: 10.1002/onco.13530. PMID: 32949176. Case report. ˍ

Tu JH, Piao YS, Lu DH, Wang LM, Liu L, Bai DY, Han HW, Lin YK, Zhong S.
An adult case of diffuse midline glioma with H3 K27M mutation.
Neuropathology. 2020 Sep 20, 2020;40(6):627-631
. doi: 10.1111/neup.12689. PMID: 32954563. Case report. ˍ

Ciusani E, Vasco C, Rizzo A, Girgenti V, Padelli F, Pellegatta S, Fariselli L, Bruzzone MG, Salmaggi A.
MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet.
Nutr Cancer. 2020 Sep 21, 2021;73(11-12):2315-2322
. doi: 10.1080/01635581.2020.1822423. PMID: 32954880. Laboratory investigation. ˍ

Jang BS, Park AJ, Jeon SH, Kim IH, Lim DH, Park SH, Lee JH, Chang JH, Cho KH, Kim JH, Sunwoo L, Choi SH, Kim IA.
Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07).
(Basel). 2020 Sep 21, 2020;12(9):E2706. doi: 10.3390/cancers12092706. PMID: 32967367. Observational study. ˍ

Rigamonti A, Simonetti G, Silvani A, Rudà R, Franchino F, Villani V, Pace A, Merli R, Servida M, Picca A, Berzero G, Cerase A, Chiarotti I, Spena G, Salmaggi A; neurooncology group of SNO (Society of Hospital Neurosciences, Italy).
Adult brainstem glioma: a multicentre Observational study of 47 Italian patients.
Neurol Sci. 2020 Sep 21, 2021;42(5):1879-1886
. doi: 10.1007/s10072-020-04725-7. PMID: 32954462. Observational study. ˍ

Biau J, Thivatx E, Chautard E, Stefan D, Boone M, Chauffert B, Bourgne C, Richard D, Molna I, Levesque S, Bellini R, Kwiatkowski F, Karayan-Tapon L, Verrelle P, Godfraind C, Durando X.
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma.
Radiother Oncol. 2020 Sep 22, 2021;154:227-234
. doi: 10.1016/j.radonc.2020.09.036. PMID: 32976869. Interventional study. ˍ

Hua T, Zhou W, Zhou Z, Guan Y, Li M.
Heterogeneous parameters based on 18F-FET PET imaging can non-invasively predict tumor grade and isocitrate dehydrogenase gene 1 mutation in untreated gliomas.
Quant Imaging Med Surg. 2020 Sep 22, 2021;11(1):317-327
. doi: 10.21037/qims-20-723. PMID: 33392031. Observational study. ˍ

Khalafallah AM, Jimenez AE, Patel P, Huq S, Azmeh O, Mukherjee D.
A novel online calculator predicting short-term postoperative outcomes in patients with metastatic brain tumors.
J Neurooncol. 2020 Sep 22, 2020;149(3):429-436
. doi: 10.1007/s11060-020-03626-1. PMID: 32964354. Observational study. ˍ

Chen X, Zeng M, Tong Y, Zhang T, Fu Y, Li H, Zhang Z, Cheng Z, Xu X, Yang R, Liu Z, Wei X, Jiang X.
Automatic Prediction of MGMT Status in Glioblastoma via Deep Learning-Based MR Image Analysis.
Biomed Res Int. 2020 Sep 23, 2020;2020:9258649
. doi: 10.1155/2020/9258649. PMID: 33029531. Observational study. ˍ

Wirsching HG, Roelcke U, Weller J, Hundsberger T, Hottinger AF, von Moos R, Caparrotti F, Conen K, Remonda L, Roth P, Ochsenbein AF, Tabatabai G, Weller M.
MRI and 18FET-PET predict survival benefit from bevacizumab plus radiotherapy in patients with IDH wild-type glioblastoma: results from the randomized ARTE trial.
Clin Cancer Res. 2020 Sep 23, 2021;27(1):179-188
. doi: 10.1158/1078-0432.CCR-20-2096. PMID: 32967939. Interventional study. ˍ

Varma A, Gopalakrishnan CV, Kachare N, Panikar D.
Glioblastoma Masquerading as a Parafalcine Meningioma: A Pathological Surprise!
J Neurosci Rural Pract. 2020 Sep 25, 2020;11(4):668-669
. doi: 10.1055/s-0040-1716775. PMID: 33144813. Case report. ˍ

Liu Y, Strawderman MS, Warren KT, Richardson M, Serventi JN, Mohile NA, Milano MT, Walter KA.
Clinical Efficacy of Tumor Treating Fields for Newly Diagnosed Glioblastoma.
Anticancer Res. 2020 Sep 28, 2020;40(10):5801-5806
. doi: 10.21873/anticanres.14597. PMID: 32988908. Observational study. ˍ

Swellam M, Bakr NM, El Magdoub HM, Hamza MS, Ezz El Arab LR.
Emerging role of miRNAs as liquid biopsy markers for prediction of glioblastoma multiforme prognosis.
J Mol Neurosci. 2020 Sep 28, 2021;71(4):836-844
. doi: 10.1007/s12031-020-01706-5. PMID: 32989634. Laboratory investigation. ˍ

Mahiat C, Capes A, Duprez T, Whenham N, Duck L, Labriola L.
Central diabetes insipidus induced by temozolomide: A report of two cases.
J Oncol Pharm Pract.
2020 Sep 29, 2021;27(4):1040-1045. doi: 10.1177/1078155220961551. PMID: 32990192. Case report. ˍ

Ma L, Li G, Wei M.
Neutrophil-to-Lymphocyte Ratio and Its Changes are Related to Grade II-IV Glioma Recurrence.
Cancer Manag Res. 2020 Sep 30, 2020;12:9429-9434
. doi: 10.2147/CMAR.S267523. PMID: 33061630. Observational study. ˍ